Crystalline forms of parp inhibitors
US-2017267683-A1 · Sep 21, 2017 · US
US10280140B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10280140-B2 |
| Application number | US-201715418889-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2017 |
| Priority date | Jul 30, 2014 |
| Publication date | May 7, 2019 |
| Grant date | May 7, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for the production of a pyrrolidine derivative.
Opening claim text (preview).
What is claimed is: 1. A method for producing a pyrrolidine derivative, which comprises the following steps: 1) Incubating (a) 5-oxo-pyrrolidine-2-carboxylic acid derivative of formula I wherein R 1 is a linear alkyl residue with C 1 -C 6 ; R 2 and R 3 are each independent from each other selected from the group consisting of: with each: n =0- 20, X ═O or S, and (b) a compound selected from the group consisting of: N-substituted diamine of formula II where R 4 is a linear alkyl or acyl residue with C 2 to C 22 , and n =1-6; and N-substituted monoamine of formula III where R 5 is a linear alkyl or acyl residue with C 2 to C 22 ; and N-substituted fatty amide of formula IV where R 6 is a linear alkyl group with C 2 to C 24 ; under appropriate reaction conditions to obtain a pyrrolidine derivative, and 2) Isolating the obtained pyrrolidine derivative. 2. The method of claim 1 , wherein any of the N-substituted diamine or N-substituted monoamine or N-substituted fatty amide comprises at R 4 or R 5 or R 6 any of a mono- or poly-unsaturated alkyl or acyl residue. 3. The method of claim 1 , wherein the 5-oxo-pyrrolidine-2- carboxylic acid derivative is a 5-oxo-pyrrolidine-2-carboxylic acid methyl ester of formula V 4. The method of claim 1 , wherein the N-substituted diamine is cocospropylene-1,3-diamine of formula VI: 5. The method of claim 4 , wherein the cocospropylene-1,3-diamine comprises approximately 70 mol-% of dodecylpropylenediamine and approximately 30 mol-% of tetradecylpropylenediamine. 6. The method of claim 1 , wherein the pyrrolidine derivative is glucoprotamin of formula VII: 7. The method of claim 1 , wherein the reaction conditions comprise an incubation temperature of approximately 60° C. 8. The method of claim 1 , wherein the reaction conditions comprise an incubation time of approximately 60 min. 9. The method of claim 1 , wherein the reaction conditions comprise a pressure of ≤ approximately 400 mbar. 10. The method of claim 1 , wherein a molar ratio of (a) to (b) is approximately 1 to approximately 1 up to approximately 1 to approximately 2. 11. The method of claim 1 , comprising removing reaction side products generated in step (1). 12. The method of claim 11 , wherein the reaction side product comprises methanol and the method comprises removing the methanol by distillation.
2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.